Copper to Zinc Ratio in End Stage Renal Disease Patients Outcome
NCT07109778 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-08-07
Summary
The goal of this observational clinical trial is to Study the impact of copper to zinc ratio on the outcome of ESRD patients
Conditions
- ESRD (End Stage Renal Disease)
- Control Condition
Sponsors & Collaborators
-
Minia University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-08-01
- Primary Completion
- 2026-02-01
- Completion
- 2026-04-01
Countries
- Egypt
Study Locations
More Related Trials
-
A Novel Role of Alpha Lipoic Acid in Comparison With Selenium in Mitochondrial Resuscitation and miRNA-126 Expression in Hemodialysis Patients
NCT05266794 ·Status: COMPLETED ·Phase: PHASE4
-
Relationship of Serum Zinc Level with Severity of Diabetic Nephropathy
NCT06690034 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients
NCT05577507 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)
NCT00110929 ·Status: COMPLETED ·Phase: PHASE2
-
Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease
NCT00995163 ·Status: COMPLETED
-
Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
NCT00677534 ·Status: COMPLETED ·Phase: NA
-
Effect of Protein Restriction Plus EAA/KA Supplementation on GFR Decline in CKD
NCT05952544 ·Status: COMPLETED
-
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
NCT02888171 ·Status: COMPLETED ·Phase: NA
-
Low-Phosphate Diet and Fibroblast Growth Factor-23 Level
NCT03367338 ·Status: COMPLETED ·Phase: NA
-
Impact of Vitamin D Therapies on Chronic Kidney Disease
NCT01222234 ·Status: COMPLETED ·Phase: NA
-
Activated Charcoal Use in Chronic Kidney Disease Patients
NCT06906874 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Different Timings of Protein Supplementation in Hemodialysis Patients
NCT05953636 ·Status: COMPLETED ·Phase: NA
-
An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
NCT00834301 ·Status: UNKNOWN ·Phase: PHASE2
-
Serum Preptin Level and Its Relationship with Bone Mineral Disease in Chronic Kidney Disease Patients
NCT06594042 ·Status: NOT_YET_RECRUITING
-
Provision of Antioxidant Therapy in Hemodialysis (PATH) Study
NCT00237718 ·Status: COMPLETED ·Phase: PHASE2
-
Ergocalciferol in Chronic Kidney Disease
NCT00411294 ·Status: COMPLETED
-
Acute Changes in the Mineral Metabolism After a High Phosphorous Containing Meal in Dialysis Patients
NCT03868371 ·Status: COMPLETED ·Phase: NA
-
Effects of Mesna on Homocysteine in Kidney Failure
NCT00524199 ·Status: COMPLETED ·Phase: PHASE2
-
Magnesium Supplementation in Diabetic Nephropathy
NCT03824379 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
NCT02999204 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Gum Acacia on Chronic Kidney Disease Patients
NCT05599399 ·Status: COMPLETED ·Phase: NA
-
Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4
NCT00910130 ·Status: UNKNOWN
-
Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria
NCT00588120 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Carbamylation in Renal Disease-Modulation With Amino Acid Therapy
NCT02472834 ·Status: COMPLETED ·Phase: NA
-
Different Oral Iron Dosing Regimens in Treatment of Iron Deficency Anemia in Patients With Chronic Kidney Disease
NCT06521216 ·Status: NOT_YET_RECRUITING